Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Tarsy

Showing results (71-80 of 74) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 74 results.
Neurology|September 26, 1997
Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystoniaM F Lew, B T Adornato, D D Duane, et al.
Neurology|January 20, 2010
Novel THAP1 sequence variants in primary dystoniaJ Xiao, Y Zhao, R W Bastian, et al.
Parkinsonism & Related Disorders|November 5, 2013
Mobility, mood and site of care impact health related quality of life in Parkinson's diseaseJ G Nutt, A D Siderowf, M Guttman, et al.
Neurology|February 27, 2001
A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's diseaseI Shoulson, J Penney, M McDermott, et al.
Pageof 8

Showing results (71-80 of 74) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 74 results.
Neurology|September 26, 1997
Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystoniaM F Lew, B T Adornato, D D Duane, et al.
Neurology|January 20, 2010
Novel THAP1 sequence variants in primary dystoniaJ Xiao, Y Zhao, R W Bastian, et al.
Parkinsonism & Related Disorders|November 5, 2013
Mobility, mood and site of care impact health related quality of life in Parkinson's diseaseJ G Nutt, A D Siderowf, M Guttman, et al.
Neurology|February 27, 2001
A randomized, controlled trial of remacemide for motor fluctuations in Parkinson's diseaseI Shoulson, J Penney, M McDermott, et al.
Pageof 8